Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/22/2012US20120295953 Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
11/22/2012US20120295952 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
11/22/2012US20120295951 Genetic changes in atm and atr/chek1 as prognostic indicators in cancer
11/22/2012US20120295950 Rbp4 in insulin sensitivity/resistance, diabetes, and obesity
11/22/2012US20120295949 Microrna-based methods and compositions for the diagnosis, prognosis and treatment of tumor involving chromosomal rearrangements
11/22/2012US20120295948 Indirubin-3'-oxime derivatives as potent cyclin dependent kinase inhibitors
11/22/2012US20120295947 Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
11/22/2012US20120295946 Agents Useful for Reducing Amyloid Precursor Protein and Treating Dementia and Methods of Use Thereof
11/22/2012US20120295945 Buccal, polar and non-polar spray containing ondansetron
11/22/2012US20120295944 Treatment of hyperproliferative disorders with diarylhydantoin compounds
11/22/2012US20120295943 Cycloalkylamine derivatives
11/22/2012US20120295942 Pyrazolo[5,1b]oxazole Derivatives as CRF-1 Receptor Antagonists
11/22/2012US20120295941 Method For Producing Intermediates For The Production Of Macrocycles That Are Inhibitors Of The Proteasomic Degradation of P27, Such As Argyrin And Derivatives Thereof
11/22/2012US20120295940 Compositions for treating mastitis
11/22/2012US20120295939 Anti-viral agent
11/22/2012US20120295938 Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/22/2012US20120295937 Nitroxide therapy for the treatment of von hippel - lindau disease (vhl) and renal clear cell carcinoma (rcc)
11/22/2012US20120295936 Compositions and methods for treating seizure disorders
11/22/2012US20120295935 Mixed aminal pharmaceutical compositions and uses thereof
11/22/2012US20120295934 New Hexahydrocyclopentapyrrolone, Hexahydropyrrolopyrrolone, Octahydropyrrolopyridinone and Octahydropyridinone Compounds
11/22/2012US20120295933 Treatment of copd, gastro-esophageal reflux disease (gerd), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibators, lra drugs, anti-h1 and/or anti-h2 drugs
11/22/2012US20120295932 Method for the treatment of cancer
11/22/2012US20120295931 Spiroindoline compounds for use as anthelminthics
11/22/2012US20120295930 Novel process for the preparation of cis-nucleoside derivative
11/22/2012US20120295929 Compositions and methods for treating and preventing dermatoses
11/22/2012US20120295928 Methods for detecting and reducing impurities of lapatinib and salts thereof
11/22/2012US20120295927 Methods of using selective chemotherapeutic agents for targeting tumor cells
11/22/2012US20120295926 Selective proton coupled folate transporter and folate receptor, and garftase inhibitor compounds and methods of using the same
11/22/2012US20120295925 Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds
11/22/2012US20120295924 Thienopyrimidinedione derivatives as trpa1 modulators
11/22/2012US20120295923 Aminocyclohexanes and Aminotetrahydropyrans and Related Compounds As Gamma-Secretase Modulators
11/22/2012US20120295922 Compounds For Use In Treatment Of Mucositis
11/22/2012US20120295921 Pyridyl piperidine orexin receptor antagonists
11/22/2012US20120295920 5-amino-4-hydroxypentoyl amides
11/22/2012US20120295919 Arylpiperazine opioid receptor antagonists
11/22/2012US20120295918 Cancer treatment method
11/22/2012US20120295917 Imatinib dichloroacetate and anti-cancer agent comprising the same
11/22/2012US20120295916 Orodispersible tablet containing compacted sildenafil base
11/22/2012US20120295915 Azabenzimidazoles as fatty acid synthase inhibitors
11/22/2012US20120295914 Combination of adrenergic receptor agonist alpha-1 or alpha-2, preferably brimonidine with fillers, preferably hyaluronic acid
11/22/2012US20120295913 Bicyclic pyrazole compounds as allosteric modulators of mglur5 receptors
11/22/2012US20120295912 Piperazinylpiperidine derivatives as chemokine receptor antagonists
11/22/2012US20120295911 Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases
11/22/2012US20120295910 New Phenylsulfamoyl Benzamide Derivatives as Bradykinin Antagonists
11/22/2012US20120295909 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application
11/22/2012US20120295908 Pyrimidinyl pyridazinone derivatives
11/22/2012US20120295906 Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene-and furane-derivatives as kinase inhibitors
11/22/2012US20120295905 New anti-malarial agents
11/22/2012US20120295904 Hematopoietic growth factor mimetic small molecule compounds and their uses
11/22/2012US20120295903 Flavin derivatives
11/22/2012US20120295902 Hetaryl-[1,8]naphthyridine derivatives
11/22/2012US20120295901 Novel substituted bicyclic triazole derivatives as gamma secretase modulators
11/22/2012US20120295900 1,3-oxazines as bace 1 and/or bace2 inhibitors
11/22/2012US20120295899 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity
11/22/2012US20120295898 Antiviral Therapy
11/22/2012US20120295897 Spiro-oxindole compounds and their uses as therapeutic agents
11/22/2012US20120295896 Oxadiazole inhibitors of leukotriene production
11/22/2012US20120295895 Compounds and methods of treating ocular disorders
11/22/2012US20120295894 Pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof
11/22/2012US20120295893 Compositions and methods of counteracting residual sedative effects of sleep/ hypnotic drugs
11/22/2012US20120295892 Gabaergic receptor subtype selective ligands and their uses
11/22/2012US20120295891 Novel substituted triazole derivatives as gamma secretase modulators
11/22/2012US20120295890 Glycosaminoglycan inhibitors
11/22/2012US20120295889 3-Arylamino Pyridine Derivatives
11/22/2012US20120295888 Use of an adrenal hormone-modifying agent
11/22/2012US20120295887 Pharmaceutically acceptable salts of pyrrolo-nitrogenous heterocyclic derivatives, preparation method and medical use thereof
11/22/2012US20120295886 Antiviral compounds and their methods of use
11/22/2012US20120295885 Inhibitors of bruton's tyrosine kinase
11/22/2012US20120295884 Complement pathway modulators and uses thereof
11/22/2012US20120295883 Compounds
11/22/2012US20120295882 Tricyclic Derivatives and Their Pharmaceutical Use and Compositions
11/22/2012US20120295881 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy
11/22/2012US20120295880 Compounds With Modifying Activity Enhanced Under Hypoxic Conditions
11/22/2012US20120295879 NK1 Antagonists
11/22/2012US20120295878 Method for the treatment of cancer
11/22/2012US20120295877 Therapeutic Compounds
11/22/2012US20120295875 Boron-containing small molecules as antiprotozoal agents
11/22/2012US20120295874 Coferons and methods of making and using them
11/22/2012US20120295873 Branched soluble glucose polymers for peritoneal dialysis
11/22/2012US20120295872 Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases
11/22/2012US20120295871 Heparin-based compositions and methods for the inhibition of metastasis
11/22/2012US20120295870 Cross-linking of low-molecular weight and hih-molecular weight polysaccharides, preparation of injectable monphase hydrogels, polysaccharides and hydrogels obtained
11/22/2012US20120295869 Sterile Hyaluronic Acid Solutions
11/22/2012US20120295868 Medical Uses of Glucans
11/22/2012US20120295867 Method and pharmaceutical to treat spinal discs
11/22/2012US20120295866 Synthesis And Use Of Glycoside Pro-Drug Analogs
11/22/2012US20120295865 Shark-like chondroitin sulphate and process for the preparation thereof
11/22/2012US20120295864 Method for treating acute myeloid leukemia
11/22/2012US20120295863 Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Prevention and Treatment of Neurodegenerative Diseases
11/22/2012US20120295862 Nucleobase-functionalized conformationally restricted nucleotides and oligonucleotides for targeting of nucleic acids
11/22/2012US20120295861 Combination Therapy With Organic Arsenicals
11/22/2012US20120295860 Organic compounds
11/22/2012US20120295859 Method for treatment of malaria
11/22/2012US20120295858 Use of danshensu, notoginsenoside r1 or their combination in preparation of medicaments for preventing and treating diseases caused by microcirculation disorder
11/22/2012US20120295857 Extract obtained by a commercially viable process for the extraction of furostanolic saponins from fenugreek seeds, in which one of the compounds in the extract is protodioscin
11/22/2012US20120295856 Fredericamycin derivatives
11/22/2012US20120295854 Methods of Inducing Tissue Regeneration
11/22/2012US20120295853 Neuronal pain pathway
11/22/2012US20120295845 Imidazo-pyrazoles as gpr119 inhibitors
11/22/2012US20120295841 Sanglifehrin Based Compounds
1 ... 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 ... 7860